Melhores Tumor adrenal médicos em Israel - TOP-7 médicos

O Prof. Merimsky chefia a Unidade de Oncologia de Tecidos Moles e Ossos no Sourasky Medical Center, especializando-se em tumores raros e complexos.

• Mais de 30 anos de experiência em oncologia, com foco em sarcomas
• Formação especializada no Institut Gustave Roussy, em Paris, para o tratamento de sarcomas
• Membro do corpo docente da ESMO para Sarcomas de Tecidos Moles e Ossos
• Realizar pesquisas extensas em imunologia tumoral e terapias alvo

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

O Dr. Levin coordena o programa nacional de sarcoma pediátrico, tratando cânceres ósseos e de tecidos moles. Ele estudou em um centro de oncologia ortopédica líder mundial na Itália.

• Pediatra sênior com especialização em hematologia e oncologia pediátrica
• Diretor do departamento de hematologia e oncologia infantil do Sourasky Medical Center
• Focar no tratamento de distúrbios sanguíneos e cânceres em crianças
• Membro da Sociedade de Hematologia e Oncologia Pediátrica de Israel (ISPHO)
• Chefiar um departamento de distúrbios de coagulação e trombose

Diretor de internação oncológica no Centro Médico Ichilov de Tel Aviv, o Dr. Stepfansky lidera estudos clínicos em oncologia nas fases 1-3.

• Especializar-se em medicina interna e oncologia
• Possuir mais de 20 anos de experiência clínica em oncologia
• Ser investigador principal e secundário em ensaios clínicos oncológicos
• Praticar na Universidade de Grodno e no Centro Médico Mozir

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.